341 related articles for article (PubMed ID: 11157879)
1. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
2. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
[TBL] [Abstract][Full Text] [Related]
3. Effects of acetazolamide on passive and active transport of fluorescein across the normal BRB.
Moldow B; Sander B; Larsen M; Lund-Andersen H
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1770-5. PubMed ID: 10393047
[TBL] [Abstract][Full Text] [Related]
4. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy.
Sander B; Larsen M; Engler C; Strøm C; Moldow B; Larsen N; Lund-Andersen H
Br J Ophthalmol; 2002 Mar; 86(3):316-20. PubMed ID: 11864891
[TBL] [Abstract][Full Text] [Related]
5. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
[TBL] [Abstract][Full Text] [Related]
6. Fluorescein transport through the blood-aqueous and blood-retinal barriers in diabetic macular edema.
Sander B; Best J; Johansen S; Kessel L; Moldow B
Curr Eye Res; 2003 Oct; 27(4):247-52. PubMed ID: 14562176
[TBL] [Abstract][Full Text] [Related]
7. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
[TBL] [Abstract][Full Text] [Related]
8. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M
Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
[TBL] [Abstract][Full Text] [Related]
9. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
Lund-Andersen H; Krogsaa B; la Cour M; Larsen J
Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
[TBL] [Abstract][Full Text] [Related]
10. Relationship between macular microcirculation and progression of diabetic macular edema.
Sakata K; Funatsu H; Harino S; Noma H; Hori S
Ophthalmology; 2006 Aug; 113(8):1385-91. PubMed ID: 16877077
[TBL] [Abstract][Full Text] [Related]
11. Vitreous fluorophotometry in aphakic or pseudophakic eyes with persistent cystoid macular edema.
Miyake K
Jpn J Ophthalmol; 1985; 29(2):146-52. PubMed ID: 4046223
[TBL] [Abstract][Full Text] [Related]
12. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema.
Kang SW; Park CY; Ham DI
Am J Ophthalmol; 2004 Feb; 137(2):313-22. PubMed ID: 14962423
[TBL] [Abstract][Full Text] [Related]
13. Retinal hemodynamics in proliferative diabetic retinopathy. A laser Doppler velocimetry study.
Grunwald JE; Brucker AJ; Grunwald SE; Riva CE
Invest Ophthalmol Vis Sci; 1993 Jan; 34(1):66-71. PubMed ID: 8425842
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
15. [The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements].
Schalnus R; Ohrloff C
Klin Monbl Augenheilkd; 1993 Apr; 202(4):281-7. PubMed ID: 8331884
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast enhanced MRI in patients with diabetic macular edema: initial results.
Trick GL; Liggett J; Levy J; Adamsons I; Edwards P; Desai U; Tofts PS; Berkowitz BA
Exp Eye Res; 2005 Jul; 81(1):97-102. PubMed ID: 15978260
[TBL] [Abstract][Full Text] [Related]
17. Topography of diabetic macular oedema compared with fluorescein angiography.
Neubauer AS; Chryssafis C; Priglinger SG; Haritoglou C; Thiel M; Welge-Lüssen U; Kampik A; Ulbig MW
Acta Ophthalmol Scand; 2007 Feb; 85(1):32-9. PubMed ID: 17244207
[TBL] [Abstract][Full Text] [Related]
18. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
19. Estimation of permeability in blood-retinal barrier.
Kojima M; Yoshida A; Ishiko S; Tanaka K
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):419-27. PubMed ID: 2227794
[TBL] [Abstract][Full Text] [Related]
20. [Tyndallometry in patients with diabetic macular edema before and after central laser coagulation].
Wiedemann R; Walter A; Wiedemann P
Klin Monbl Augenheilkd; 1998 Jan; 212(1):32-6. PubMed ID: 9541892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
